Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00496509 |
A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients with Advanced Colorectal Cancer and Liver Metastases.
Condition | Intervention | Phase |
---|---|---|
Hepatocellular Carcinoma |
Drug: ZD6474 (Zactima) Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MR) Procedure: Biomarker Draws |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Dose Comparison, Single Group Assignment, Efficacy Study |
Official Title: | A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients With Advanced Colorectal Cancer and Liver Metastases |
Enrollment: | 24 |
Study Start Date: | September 2006 |
Study Completion Date: | October 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | D4200C00050 |
Study First Received: | July 3, 2007 |
Last Updated: | December 14, 2007 |
ClinicalTrials.gov Identifier: | NCT00496509 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
ZD6474 Colorectal Cancer Liver Metastases Biomarkers |
Liver Diseases Digestive System Neoplasms Carcinoma, Hepatocellular Gastrointestinal Diseases Colonic Diseases Liver neoplasms Intestinal Diseases Rectal Diseases Intestinal Neoplasms |
Carcinoma Liver Neoplasms Digestive System Diseases Neoplasm Metastasis Gastrointestinal Neoplasms Adenocarcinoma Colorectal Neoplasms Hepatocellular carcinoma Neoplasms, Glandular and Epithelial |
Neoplasms Neoplasms by Site Neoplasms by Histologic Type |